Organigram Global (OGI) Change in Working Capital (2024 - 2026)
Organigram Global (OGI) posted quarterly Change in Working Capital of -$21.5 billion for Q1 2026, down 323.52% year-on-year from $9.6 billion in Q1 2025, and down 143828307.77% on a QoQ basis from -$14920.4 in Q4 2025.
Organigram Global (OGI) Change in Working Capital (2024 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Change in Working Capital for 3 consecutive years, with -$21.5 billion the latest figure, recorded in Q1 2026.
- Quarterly Change in Working Capital fell 323.52% year-over-year to -$21.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.9 billion (changed N/A YoY) and the FY2020 annual result came in at $141123.0, changed N/A from the prior year.
- Change in Working Capital fell to -$21.5 billion in Q1 2026 per OGI's latest filing, from -$14920.4 in the prior quarter.
- Over the last five years, Change in Working Capital for OGI reached as high as $9.6 billion in Q1 2025 and fell as low as -$21.5 billion in Q1 2026.
- A 3-year average of -$3.0 billion and a median of -$31060.0 in 2025 frame the typical range for Change in Working Capital.
- Annual changes were most pronounced in 2025 — Change in Working Capital surged 68.39% — and 2026, when it plunged 323.52%.
- Year by year, Change in Working Capital stood at -$47199.5 in 2024, then jumped by 68.39% to -$14920.4 in 2025, then plunged by 143828307.77% to -$21.5 billion in 2026.
- According to Business Quant data, Change in Working Capital over the past three periods registered -$21.5 billion, -$14920.4, and $9.6 billion for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -617.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | -21.46 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.46 Bn |
| Mar 31, 2026 | -21.46 Bn |
| Dec 31, 2025 | -14,920.41 |
| Dec 31, 2025 | -14,920.41 |
| Mar 31, 2025 | 9.60 Bn |
| Mar 31, 2025 | 9.60 Bn |
| Dec 31, 2024 | -47,199.51 |
| Dec 31, 2024 | -47,199.51 |